Papers
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study
BMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7300.1447 (Published 16 June 2001) Cite this as: BMJ 2001;322:1447
Data supplement
Figure1 Formation of the study population.
(F1) Formation of the study population. In the screening phase (phase 1), participants scoring £ 24 in the mini-mental state examination (MMSE) were invited to the clinical phase (phase 2) consisting of medical history, neurological and cardiovascular examinations, and detailed neuropsychological evaluation. Participants with possible dementia were invited to the differential diagnosis phase (phase 3), which included magnetic resonance imaging, blood tests, chest radiograph, electrocardiogram, and cerebrospinal fluid analysis
Cited by...
- Association Between Fluctuations in Blood Lipid Levels Over Time With Incident Alzheimer Disease and Alzheimer Disease-Related Dementias
- Leveraging Electronic Medical Records and Knowledge Networks to Predict Disease Onset and Gain Biological Insight Into Alzheimers Disease
- Associations of Physical Activity with Alzheimers Disease Pathologies and Cognition: The CABLE Study
- Dementia Risk and Dynamic Response to Exercise: A non-randomized clinical trial
- Assessing the role of vascular risk factors in dementia: Mendelian randomization meta-analysis and comparison with observational estimates
- Development of cognition decline in non-acute symptomatic patients with cerebral small vessel disease: Non-Acute Symptomatic Cerebral Ischemia Registration study (NASCIR)--rationale and protocol for a prospective multicentre observational study
- Sex Differences in the Association Between Midlife Cardiovascular Conditions or Risk Factors With Midlife Cognitive Decline
- Total Cholesterol and APOE-Related Risk for Alzheimers Disease in the Alzheimers Disease Neuroimaging Initiative
- Vascular risk burden is a key player in the early progression of Alzheimers disease
- dynaPhenoM: Dynamic Phenotype Modeling from Longitudinal Patient Records Using Machine Learning
- Hypertension and Hypercholesterolemia Modify Dementia Risk in Relation to APOE {varepsilon}4 Status
- Association of midlife vascular risk and AD biomarkers with subsequent cognitive decline
- Ventricular expansion, white matter hyperintensities, and global cognition in Alzheimers disease and normal aging
- Predicting dementia diagnosis from cognitive footprints in electronic health records: a case-control study protocol
- Vascular and metabolic risk factor differences prior to dementia diagnosis: a multidatabase case-control study using European electronic health records
- Revised Framingham Stroke Risk Profile: Association with Cognitive Status and MRI-Derived Volumetric Measures
- Hemodynamic Instability in Heart Failure Intensifies Age-Dependent Cognitive Decline
- Association of out-of-pocket costs on adherence to common neurologic medications
- Day-to-Day Home Blood Pressure Variability is Associated with Cerebral Small Vessel Disease Burden in a Memory Clinic Population
- Midlife Hypertension and Alzheimers Disease: A Systematic Review and Meta-Analysis
- Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimers Disease Pathology
- The Association of Late-Life Diabetes Status and Hyperglycemia With Incident Mild Cognitive Impairment and Dementia: The ARIC Study
- DNA methylation age acceleration and risk factors for Alzheimers disease
- Systolic Blood Pressure and Cognitive Decline in Older Adults With Hypertension
- Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-{beta}
- Subtle Cognitive Impairment and Alzheimers Disease-Type Pathological Changes in Cerebrospinal Fluid are Common Among Neurologically Healthy Subjects
- The Coming of Age of the Angiotensin Hypothesis in Alzheimers Disease: Progress Toward Disease Prevention and Treatment?
- Association between exercise and the risk of dementia: results from a nationwide longitudinal study in China
- Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimers disease: a rationale for multi-nutrient dementia prevention
- Female sex, early-onset hypertension, and risk of dementia
- Diabetes and Alzheimers Disease: Can Tea Phytochemicals Play a Role in Prevention?
- The Gut Microbiota and Alzheimers Disease
- 27-Hydroxycholesterol impairs neuronal glucose uptake through an IRAP/GLUT4 system dysregulation
- Effect of Vascular Risk Factors on the Progression of Mild Alzheimers Disease and Lewy Body Dementia
- Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association
- Chronotropic Response and Cognitive Function in a Cohort at Risk for Alzheimers Disease
- Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis
- Small vessels, dementia and chronic diseases-molecular mechanisms and pathophysiology
- Alzheimers Disease Risk Genes and Lipid Regulators
- Association of Plasma A{beta}40 Peptides, But Not A{beta}42, with Coronary Artery Disease and Diabetes Mellitus
- Prevention Trials in Alzheimers Disease: Current Status and Future Perspectives
- Amyloid burden and sleep blood pressure in amnestic mild cognitive impairment
- Diet and Inflammation in Alzheimers Disease and Related Chronic Diseases: A Review
- Systolic Blood Pressure Variation and Mean Heart Rate Is Associated With Cognitive Dysfunction in Patients With High Cardiovascular Risk
- Adult asthma increases dementia risk: a nationwide cohort study
- Autoantibodies Toward the Angiotensin 2 Type 1 Receptor: A Novel Autoantibody in Alzheimers Disease
- Midlife Hypertension Risk and Cognition in the Non-Demented Oldest Old: Framingham Heart Study
- Hypercholesterolaemia-induced oxidative stress at the blood-brain barrier
- Is Hypertension Associated With an Accelerated Aging of the Brain?
- Early Adult to Midlife Cardiovascular Risk Factors and Cognitive Function
- Association of type 2 diabetes with brain atrophy and cognitive impairment
- Temporal Evolution of Cognitive Changes in Incident Hypertension: Prospective Cohort Study Across the Adult Age Span
- Plant Sterols the Better Cholesterol in Alzheimer's Disease? A Mechanistical Study
- Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease
- The Controversies of Statin Therapy: Weighing the Evidence
- Blood Pressure Trajectories From Midlife to Late Life in Relation to Dementia in Women Followed for 37 Years
- Midlife and Late-Life Blood Pressure and Dementia in Japanese Elderly: The Hisayama Study
- Intensive Blood Pressure Control Affects Cerebral Blood Flow in Type 2 Diabetes Mellitus Patients
- {gamma}-Secretase-dependent amyloid-{beta} is increased in Niemann-Pick type C: A cross-sectional study
- Midlife cholesterol level and dementia 32 years later: Is there a risk?
- Apolipoprotein A-I Deficiency Increases Cerebral Amyloid Angiopathy and Cognitive Deficits in APP/PS1{Delta}E9 Mice
- Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons
- Lowering Midlife Levels of Systolic Blood Pressure as a Public Health Strategy to Reduce Late-Life Dementia: Perspective From the Honolulu Heart Program/Honolulu Asia Aging Study
- Liver X Receptor Agonist Treatment Ameliorates Amyloid Pathology and Memory Deficits Caused by High-Fat Diet in APP23 Mice
- Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
- Metabolic Syndrome Over 10 Years and Cognitive Functioning in Late Midlife: The Whitehall II study
- Treatment of vascular risk factors is associated with slower decline in Alzheimer disease
- Association between mid-life marital status and cognitive function in later life: population based cohort study
- Duration of antihypertensive drug use and risk of dementia: A prospective cohort study
- Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons
- Vascular risk factors and dementia: How to move forward?
- Metabolic Syndrome and Risk for Incident Alzheimer's Disease or Vascular Dementia: The Three-City Study
- STATINS, INCIDENT ALZHEIMER DISEASE, CHANGE IN COGNITIVE FUNCTION, AND NEUROPATHOLOGY
- Childhood cognitive ability and risk of late-onset Alzheimer and vascular dementia
- Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease
- Abnormal Regional Cerebral Blood Flow in Cognitively Normal Elderly Subjects With Hypertension
- Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
- The metabolic syndrome is associated with decelerated cognitive decline in the oldest old
- Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease
- Alzheimer-Like Changes in Rat Models of Spontaneous Diabetes
- The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration
- Less Atherosclerosis and Lower Blood Pressure for a Meaningful Life Perspective With More Brain
- "Skittish" Abca2 Knockout Mice Display Tremor, Hyperactivity, and Abnormal Myelin Ultrastructure in the Central Nervous System
- Relationship of vascular risk to the progression of Alzheimer disease
- Iron genes, iron load and risk of Alzheimer's disease.
- Association of metabolic syndrome with Alzheimer disease: a population-based study.
- Garlic Reduces Dementia and Heart-Disease Risk
- Can We Escape Stroke and Alzheimer Disease?
- Midlife Pulse Pressure and Incidence of Dementia: The Honolulu-Asia Aging Study
- Lack of ABCA1 Considerably Decreases Brain ApoE Level and Increases Amyloid Deposition in APP23 Mice
- Statins and cognitive function in the elderly: The Cardiovascular Health Study
- Serum cholesterol and risk of Alzheimer disease: A community-based cohort study
- Relationship Between Arterial Stiffness and Cognitive Function in Elderly Subjects With Complaints of Memory Loss
- May 24 Highlight and Commentary: Timing is of the essence
- High total cholesterol levels in late life associated with a reduced risk of dementia
- Hypertension and cognitive performance in African Americans with Alzheimer disease